1Kandaswami C, Lee LT, Lee PP, et al. The antitumor activities of flavonoids [J]. In Vivo,2005,19(5) :895-909.
2Ren W, Qiao Z, Wang H, et al. Flavonoids: promising anticancer agents [J]. Med Res Rev, 2003, 23 (4) : 519-534.
3Suryadinata R, Sadowski M, Sarcevic B. Control of cell cycle progression by phosphorylation of cyclin-dependent kinase (CDK) substrates [ J ]. Biosci Rep,2010,30(4) :243-255.
4Yu J, Guo QL, You QD, et al. Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcino- ma BGC-823 cells[J]. Carcinogene- sis, 2007, 28 ( 3 ) : 632-638.
5Choi H J, Lira do Y, Park JH. In- duction of GI and G2/M cell cycle arrests by the dietary compound 3, 3'-diindolyhnethane in HT-29 human colon cancer cells[ J ]. BMC Gastro- enterol, 2009, 9: 39.
6Vermeulen K, van Bockstaele DR, Bememan ZN. The cell cycle: a re- view of regulation, deregulation and therapeutic targets in cancer [ J ]. Cell Prolif, 2003, 36(3) : 131-149.
7Choedon T, Shukla SK, Kumar V. Chemopreventive and anti-cancer properties of the aqueous extract of flowers of Butea monosperma [ J ]. J Ethnopharmacol, 2009, 122 (2) : 294-303.
8Parajuli P, Joshee N, Rimando AM, et al. In vitro antitumor mechanisms of various Scutellaria extracts and constituent flavonoids [ J ]. Planta medica, 2009, 75(1): 41-48.
9Chung H, Jung YM, Shin DH, et al. Antieancer effects of wogonin in both estrogen receptor-positive and- negative human breast cancer cell lines in vitro and in nude mice xenografts[J1. Int J Cancer, 2008, 122 (4) : 816-822.
10Pidgeon GP, Kandouz M, Meram A, et al. Mechanisms controlling cell cycle arrest and induction of apopto- sis after 12-1ipoxygenase inhibition in prostate cancer cells [ J ]. Cancer Res, 2002, 62(9) : 2721-2727.
7Gridelli C, Perrone F, Monfardini S. Lung cancer in the elderly[J]. Eur J Cancer, 1997,33 ( 33 ) : 2313-2314.
8孙燕译.成人及儿童肿瘤内科分册[M].北京:学术期刊出版社,1988:29.
9Clarke SJ, Abratt R, Goedhals L, et al. Phase II trial of pemetrexed disodium in chemotherapy--naive patients with advanced non-small-cell lung cancer[J]. Ann Oncol, 2002, 13 (5) :737-741.
10Rusthoven JJ,Eisenhauer E, Butts C, et al. Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study[ J]. J Clin Oncol, 1999,17 (4) : 1194-1199.
